These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 11156729)

  • 1. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
    Campbell KR; Mahaffey KW; Lewis BE; Weitz JI; Berkowitz SD; Ohman EM; Califf RM
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():14F-9. PubMed ID: 11156729
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost analysis of bivalirudin in percutaneous coronary intervention.
    Lauer MA
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():37F-40. PubMed ID: 11156733
    [No Abstract]   [Full Text] [Related]  

  • 3. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.
    Chew DP
    Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of bivalirudin instead of heparin during a percutaneous coronary intervention in a patient with severe thrombocytopenia.
    Bejarano J; Muniz AJ
    J Invasive Cardiol; 2004 Sep; 16(9):535-6. PubMed ID: 15353815
    [No Abstract]   [Full Text] [Related]  

  • 5. Bivalirudin: a direct thrombin inhibitor.
    Gladwell TD
    Clin Ther; 2002 Jan; 24(1):38-58. PubMed ID: 11833835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building a stronger foundation: improved antithrombin therapy with bivalirudin in percutaneous coronary intervention.
    Knopf W
    J Invasive Cardiol; 2002 Apr; 14 Suppl B():1B. PubMed ID: 11967384
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of heparin-associated thrombocytopenia and thrombosis using Hirulog.
    Chamberlin JR; Lewis B; Leya F; Wallis D; Messmore H; Hoppensteadt D; Walenga JM; Moran S; Fareed J; McKiernan T
    Can J Cardiol; 1995 Jun; 11(6):511-4. PubMed ID: 7780873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results.
    Mahaffey KW; Lewis BE; Wildermann NM; Berkowitz SD; Oliverio RM; Turco MA; Shalev Y; Ver Lee P; Traverse JH; Rodriguez AR; Ohman EM; Harrington RA; Califf RM;
    J Invasive Cardiol; 2003 Nov; 15(11):611-6. PubMed ID: 14608128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction angina. Hirulog Angioplasty Study Investigators.
    Bittl JA; Feit F
    Am J Cardiol; 1998 Oct; 82(8B):43P-49P. PubMed ID: 9809891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of bivalirudin.
    Reed MD; Bell D
    Pharmacotherapy; 2002 Jun; 22(6 Pt 2):105S-111S. PubMed ID: 12064567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin.
    Ramana RK; Lewis BE
    Vasc Health Risk Manag; 2008; 4(3):493-505. PubMed ID: 18827868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA panel votes against approval for bivalirudin.
    Piña I
    Circulation; 1999 Mar; 99(10):1277. PubMed ID: 10077507
    [No Abstract]   [Full Text] [Related]  

  • 13. Hirudin-based anticoagulant strategies for patients with suspected heparin-induced thrombocytopenia undergoing percutaneous coronary interventions and bypass grafting.
    Becker RC
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():59-68. PubMed ID: 11155195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
    Lubenow N; Greinacher A
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():47-57. PubMed ID: 11155194
    [No Abstract]   [Full Text] [Related]  

  • 15. Bivalirudin compared with heparin during coronary angioplasty for thrombus-containing lesions.
    Shah PB; Ahmed WH; Ganz P; Bittl JA
    J Am Coll Cardiol; 1997 Nov; 30(5):1264-9. PubMed ID: 9350925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of bivalirudin in percutaneous coronary intervention.
    Topol EJ
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():1F. PubMed ID: 11156726
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation between abrupt vessel closure and the anticoagulant response to heparin or bivalirudin during coronary angioplasty.
    Bittl JA; Ahmed WH
    Am J Cardiol; 1998 Oct; 82(8B):50P-56P. PubMed ID: 9809892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: a thrombus in the venous reservoir while using bivalirudin in a patient with heparin-induced thrombocytopenia undergoing heart transplantation.
    Wong JK; Tian Y; Shuttleworth P; Caffarelli AD; Reitz BA; Mora-Mangano CT
    Anesth Analg; 2010 Sep; 111(3):609-12. PubMed ID: 20686010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators.
    Bittl JA; Strony J; Brinker JA; Ahmed WH; Meckel CR; Chaitman BR; Maraganore J; Deutsch E; Adelman B
    N Engl J Med; 1995 Sep; 333(12):764-9. PubMed ID: 7643883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant for primary percutaneous coronary intervention - the last dance for unfractionated heparin?
    Silvain J; Montalescot G
    Arch Cardiovasc Dis; 2012 May; 105(5):259-61. PubMed ID: 22709466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.